XML 32 R12.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions, Dispositions and Plant Closures
 12 Months Ended
Dec. 31, 2025
Acquisitions, Dispositions and Plant Closures [Abstract]  
Acquisitions, Dispositions and Plant Closures Acquisitions, Dispositions and Plant Closures
Acquisitions
•Nutrinova Joint Venture
In September 2023, the Company formed a food ingredients joint venture with Mitsui under the name Nutrinova. The Company contributed receivables, inventory, property, plant and equipment, certain other assets, liabilities, technology and employees of its food ingredients business while retaining a 30% interest in the joint venture. Mitsui acquired the remaining 70% interest in the food ingredients business for a purchase price of $503 million, subject to transaction adjustments. The Company accounted for its interest in the joint venture as an equity method investment, and its portion of the results will continue to be included in the Engineered Materials segment. A gain on the transaction of $515 million is included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations for the year ended December 31, 2023.
Dispositions
•    Micromax
On February 2, 2026, the Company completed the sale of the Micromax® business to Element Solutions Inc for a purchase price of $492 million, subject to customary transaction adjustments. The divestiture does not represent a strategic shift in the Company's future operations and financial results. The Micromax® business is included in the Engineered Materials segment and is classified as held for sale in the consolidated balance sheets as of December 31, 2025.
Assets and liabilities classified as held for sale are as follows:
As of December 31, 2025
(In $ millions)
Current assets91 
Goodwill154 
Intangible assets, net163 
Other long-term assets84 
Assets held for sale492 
Liabilities held for sale75 
Plant Closures
Exit and shutdown costs related to plant closures are as follows:
Year Ended December 31,
202520242023
(In $ millions)
Lanaken, Belgium(1)
Restructuring (Note 24)
7 — — 
Accelerated depreciation expense(2)
11 — — 
Total18 — — 
Mechelen, Belgium(3)
Restructuring (Note 24)
3 55 — 
Accelerated depreciation expense(2)
— 35 — 
Total3 90 — 
Uentrop, Germany(4)
Restructuring (Note 24)
— 16 — 
Accelerated depreciation expense(2)
— 36 14 
Loss on disposition of assets, net(5)
— — 4 
Total— 52 18 
______________________________
(1)On October 28, 2025, the Company announced the intended closure of its facility in Lanaken, Belgium to streamline the Company's production costs across its global network. This operation is included in the Company's Acetyl Chain segment. The Company intends to permanently cease all manufacturing operations during the second half of 2026.
The Company expects to incur additional exit and shutdown costs related to the intended closure of its facility in Lanaken, Belgium of $140 million, including employee termination costs, through 2027.
(2)Included in Cost of sales in the consolidated statements of operations.
(3)In February 2024, the Company announced the intended closure of its facility in Mechelen, Belgium to optimize production costs across its global network. This operation is included in the Company's Engineered Materials segment. The Company fully ceased operations during the year ended December 31, 2024.
(4)In October 2023, the Company announced the intended closure of its Polyamide 66 ("PA66") and certain High-Performance Nylon ("HPN") polymerization units at its facility in Uentrop, Germany to optimize production costs across its global network. These operations are included in the Company's Engineered Materials segment. The Company fully ceased operation of the PA66 polymerization unit and certain HPN polymerization units during the year ended December 31, 2024.
(5)Included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations.